Fingerprint
Dive into the research topics where Patrick F. Timmins is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ASO Visual Abstract: Conversion from Minimally Invasive Surgical Approaches to Open Surgery Among Endometrial Cancer Patients in the SGO Clinical Outcomes Registry
Yousif, A., Ngo, J., Abdel-Gadir, D., Rocconi, R. P., Timmins, P., Lachance, J., Michael Straughn, J., Dewdney, S., Lachance, J., Mize, B. & Chefetz, I., Jun 1 2025, In: Annals of Surgical Oncology. 32, 6, p. 4339-4340 2 p.Research output: Contribution to journal › Article › peer-review
-
Conversion from Minimally Invasive Surgical Approaches to Open Surgery Among Patients with Endometrial Cancer in the SGO Clinical Outcomes Registry
Yousif, A., Ngo, J., Abdel-Gadir, D., Rocconi, R. P., Timmins, P., Lachance, J., Straughn, J. M., Dewdney, S., Lachance, J., Mize, B. & Chefetz, I., May 2025, In: Annals of Surgical Oncology. 32, 5, p. 3458-3464 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: a retrospective observational study
Steck, A. R., Mahar, B., Martin, J. Y., McElrath, T. J., Timmins, P. F. & Barlin, J. N., Aug 2025, In: Gynecologic Oncology Reports. 60, 101793.Research output: Contribution to journal › Article › peer-review
Open Access -
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma
Barlin, J. N., Mahar, B., Ata, A., Cormier, B., Michelin, D., Salani, R., Backes, F., Levinson, K., Cantrell, L. A., Weinberg, L., Wagreich, A., Savage, D., Gasson, C., Denniston, K., Martin, J., McElrath, T. & Timmins, P. F., Jan 2024, In: Gynecologic Oncology. 180, p. 63-69 7 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
SOLO2/ENGOT-Ov21 investigators, May 2021, In: The Lancet Oncology. 22, 5, p. 620-631 12 p.Research output: Contribution to journal › Article › peer-review
Open Access392 Link opens in a new tab Scopus citations